Susquehanna International Group, LLP Aclaris Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.12 - $1.4 $8,848 - $11,060	7,900 Added 41.15%	27,100 $30,000
Q2 2024 Aug 15, 2024	BUY	$1.01 - $1.36 $5,757 - $7,752	5,700 Added 42.22%	19,200 $21,000
Q1 2024 May 07, 2024	SELL	$0.92 - $1.44 $17,756 - $27,792	-19,300 Reduced 58.84%	13,500 $16,000
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $245,888 - $2.49 Million	-384,200 Reduced 92.13%	32,800 $34,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $1.78 Million - $2.98 Million	272,100 Added 187.78%	417,000 $2.86 Million
Q2 2023 Aug 11, 2023	SELL	$7.89 - $10.64 $1.75 Million - $2.36 Million	-221,600 Reduced 60.46%	144,900 $1.5 Million
Q1 2023 May 16, 2023	BUY	$7.07 - $17.95 $2.5 Million - $6.36 Million	354,300 Added 2904.1%	366,500 $2.96 Million
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $174,826 - $224,114	12,200 New	12,200 $192,000
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $136,144 - $228,871	-13,400 Reduced 51.54%	12,600 $176,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $21,408 - $30,080	1,600 Added 6.56%	26,000 $468,000
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $73,250 - $346,625	12,500 Added 105.04%	24,400 $615,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $2.71 $1,050 - $1,897	700 Added 6.25%	11,900 $31,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $63,056 - $87,808	11,200 New	11,200 $67,000
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $329,302 - $478,381	-22,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $144,848 - $178,903	8,800 Added 62.41%	22,900 $457,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $324,582 - $406,080	14,100	14,100 $364,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.2 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.8 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.8 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.4 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account